oref1 – The newest algorithm in the #OpenAPS family and why it suits #Fiasp so well
Recently, Dana announced oref1 to the world – a new algorithm in the OpenAPS family, and in her own words: The notable difference between the […]
Recently, Dana announced oref1 to the world – a new algorithm in the OpenAPS family, and in her own words: The notable difference between the […]
The Medtronic 670G is undertaking a slow-paced roll out in the US as Medtronic tries to ensure a slow and steady, well trained delivery model […]
To some level I can’t quite believe that I’ve been enjoying the company of Fiasp for a whole month (well, in February, four weeks constitutes […]
Following the variation in absorption I felt I was seeing in my last post I’ve since had a bit of a reason to pause for thought. […]
Having used Fiasp for nearly three weeks now, I’ve seen a couple of aspects to the insulin that have had me slightly mystified, and digging back […]
I’ll cut to the chase. This has been one of the more interesting weeks in my life with diabetes. There aren’t many occasions when you […]
When I posted my first 48 hour review, less than 24 hours ago, I mentioned this graph, which suggested that it starts to take effect […]
If you follow social media, you’ll be aware that Novo Nordisk’s Faster Insulin Aspart (brand name Fiasp) became available earlier this year, having passed its […]
As many people (but let’s face it, not all) are aware, the NICE target for Hba1C level is 6.5% as this is the point at […]
Over the past couple of months, I’ve seen this question asked multiple times on many fora. Facebook, email lists and forums have all seen people […]
Copyright © 2024 | WordPress Theme by MH Themes